Text and Data Mining valid from 2018-05-30
Received: 4 March 2018
Accepted: 7 May 2018
First Online: 30 May 2018
Ethics approval and consent to participate
: This study was approved by the UCSF Institutional Review Board under study number 16–21168.
: No identifiable information or images are contained within the manuscript and therefore individual consent for publication is not applicable. The study was approved by the UCSF Institutional Review Board under study number 16–21168.
: Dr. Yom: research grant from Genentech, Merck, Bristol-Myers Squibb; Dr. Daud: research grant from Genentech, Novartis, Pfizer, Merck, BMS, Incyte; advisory board for Roche, Novartis, OncoSec; Dr. Yu: none; Drs. Xu and Wu: none.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.